KyungDong Pharm home
Prescription Medicines

Lihel Tab.

Product Category
Chronic persistent hepatitis treatment
Active Ingredients
Biphenyldimethyldicarboxylate
Appearance
A white, oval tablet.
Reimbursement Code
648100640
View Regulatory Information on the MFDS Portal ↗
1. Composition and Strength
1 tablet
- Active ingredient: Biphenyldimethyldicarboxylate (in-house specification)----25mg
- Additives (animal-derived ingredients): Lactose hydrate (cow, milk)
- Other additives: magnesium stearate, corn starch, calcium carboxymethyl cellulose

2. Effectiveness
Chronic hepatitis with continuously elevated ALT

3. Dosage and dosage
Adults: Biphenyldimethyldicarboxylate, 25-50mg once, administered orally three times a day.
Increase or decrease appropriately depending on symptoms.

4. Precautions for use
1. Do not administer to the following patients.
1) Patients with hypersensitivity to this drug or its components
2) Since this drug contains lactose, it should not be administered to patients with genetic problems such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption.

2. Administer with caution to the following patients.
1) Patients with chronic active hepatitis
2) Patients with cirrhosis

3. Adverse reactions
1) Dry mouth, nausea, and skin rash may occur, and these adverse reactions disappear with concurrent administration of anti-hypersensitivity drugs.
2) Transient jaundice may appear, but it disappears when the medication is stopped or jaundice treatment is administered together.
3) In rare cases, nausea and abdominal distension may occur, but they soon disappear.

4. Interaction
When administered together with inosine, recurrent elevations in ALT may be improved.

5. Administration to pregnant and lactating women
Do not administer to pregnant women, women who may be pregnant, or lactating women.

6. Administration to elderly people
In general, elderly people have reduced physiological function, so the dose should be administered cautiously, such as reducing the dose.

7. Impact on clinical test values
There are very few patients whose ALT rises again during treatment. ALT may increase after discontinuation of treatment, but improves with re-administration of this drug.

8. Storage and handling precautions
1) Keep out of reach of children.
2) Taking medicine out of its original container and storing it in another container may cause accidents due to misuse of the medicine or cause a decrease in the quality of the medicine, so put it in the original container and keep it tightly closed.

5. How to save
Store in a light-proof, airtight container at room temperature (1~30℃)

6. Packaging unit
30 tablets/bottle, 100 tablets/bottle

7. Period of use
36 months from date of manufacture

Product Updates

Total 2items

No.Product NameDetailsDate of ChangeDownload
2Lihel Tab.Rihel Tablet (efficacy, dosage, usage, precautions...2018.01.21HWPLeehel Jeong.hwp
1Lihel Tab.Rehel Tablet (Precautions for use)2009.10.07HWP9. Change in Reheljeong (precautions for use) (2009.10.07).hwp